Physicians' perceptions of medical representative visits in Yemen: A qualitative study

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Al Areefi, Mahmoud Abdullah ^a   Hassali, Mohamed Azmi ^b   Ibrahim, Mohamed Izham B Mohamed ^c  

^a Ministry of Public Health and Population   (Yemen)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^c Qatar University ^*  (Qatar)

Author keywords

Information; Medical representatives; Qualitative study; Yemen

Indexed keywords

CLINICAL PRACTICE; CONFLICT OF INTEREST; DRUG INDUSTRY; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; MALE; PHYSICIAN; PSYCHOLOGY; QUALITATIVE RESEARCH; YEMEN; ARTICLE; PSYCHOLOGICAL ASPECT;

ATTITUDE OF HEALTH PERSONNEL; CONFLICT OF INTEREST; DRUG INDUSTRY; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUALITATIVE RESEARCH; YEMEN;

EID: 84883225650     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-331     Document Type: Article

References (28)

1. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. Gagnon MA, Lexchin J, PLoS Med 2008 5 1 1 10.1371/journal.pmed.0050001 18177202
2. Gifts to physicians from the pharmaceutical industry: an ethical analysis. Marco CA, Moskop JC, Solomon RC, Geiderman JM, Larkin GL, Ann Emerg Med 2006 48 5 513 521 10.1016/j.annemergmed.2005.12.013 17052550
3. SBDMA, Annual report Sana'a: Supreme Board of Drug and Medical Appliances 2010
4. Yemen pharmaceutical country profile http://www.who.int/medicines/areas/ coordination/YemenPSCP-Narrative2012-12-16Final.pdf
5. Physicians and the pharmaceutical industry. Wazana A, JAMA 2000 283 3 373 10.1001/jama.283.3.373 10647801
6. Doctors and detailers: therapeutic education or pharmaceutical promotion? Lexchin J, Int J Health Serv 1989 19 4 663 679 10.2190/HUFK-5Y54-QX1E-AD62 2583883
7. Interactions between physicians and industry: a guide for clinicians. Jibson MD, FOCUS: The Journal of Lifelong Learning in Psychiatry 2007 5 4 398 406
8. Doctors and drug companies-scrutinizing influential relationships. Campbell EG, N Engl J Med 2007 357 18 1796 1797 10.1056/NEJMp078141 17978288
9. Are gifts from pharmaceutical companies ethically problematic?: a survey of physicians. Brett AS, Burr W, Moloo J, Arch Intern Med 2003 163 18 2213 10.1001/archinte.163.18.2213 14557219
10. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS, JAMA 2001 286 16 1994 1999 10.1001/jama.286.16.1994 11667936
11. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. Randall ML, Rosenbaum JR, Rohrbaugh RM, Rosenheck RA, Acad Psychiatry 2005 29 1 33 39 10.1176/appi.ap.29.1.33 15772402
12. Understanding why GPs see pharmaceutical representatives: a qualitative interview study. Prosser H, Walley T, Br J Gen Pract 2003 53 489 305 12879831
13. Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia. Doran E, Kerridge I, McNeill P, Henry D, Soc Sci Med 2006 62 6 1510 1519 10.1016/j.socscimed.2005.07.037 16143441
14. Physicians and drug representatives: exploring the dynamics of the relationship. Chimonas S, Brennan TA, Rothman DJ, J Gen Intern Med 2007 22 2 184 190 10.1007/s11606-006-0041-z 17356984
15. Prescribers and pharmaceutical representatives: why are we still meeting? Fischer MA, Keough ME, Baril JL, Saccoccio L, Mazor KM, Ladd E, Worley AV, Gurwitz JH, J Gen Intern Med 2009 24 7 795 801 10.1007/s11606-009-0989-6 19424764
16. Alfred Schutz, phenomenology and research methodology for information behaviour research. Wilson TD, The New Review of Information Behaviour Research 2002 3 71 81
17. Qualitative research: rigour and qualitative research. Mays N, Pope C, BMJ: Br Med J 1995 311 6997 109 112 10.1136/bmj.311.6997.109
18. Assessing quality in qualitative research. Mays N, Pope C, BMJ: Br Med J 2000 320 7226 50 52 10.1136/bmj.320.7226.50
19. Analysing qualitative data. Pope C, Ziebland S, Mays N, BMJ: Br Med J 2000 320 7227 114 116 10.1136/bmj.320.7227.114
20. The accuracy of drug information from pharmaceutical sales representatives. Ziegler MG, Lew P, Singer BC, JAMA 1995 273 16 1296 1298 10.1001/jama.1995.03520400066047 7715044
21. Only 6% of drug advertising material is supported by evidence. Tuffs A, BMJ 2004 328 7438 485 10.1136/bmj.328.7438.485-c 14999821
22. Drug promotion. Norris P, Herxheimer A, Lexchin J, Mansfield P, What we know, what we have yet to learn Reviews of materials in the WHO/HAI database on drug promotion Amsterdam: WHO/HAI 2005
23. Pharmaceutical representatives' beliefs and practices about their professional practice: a study in Sudan. Idris K, Mustafa A, Yousif M, EMHJ: East Mediterr Health J 2012 18 8 821 826
24. Doctors' opinions of information provided by Libyan pharmaceutical company representatives. Alssageer MA, Kowalski SR, Libyan Journal of Medicine 2012 7 10.3402/ljm.v7i0.19708
25. A qualitative study exploring medical representatives' views on current drug promotion techniques in Yemen. Al-Areefi MA, Hassali MA, Ibrahim MIBM, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 2012 12 3 143 149 10.1177/1745790412445295
26. The role of pharmaceutical marketing and other factors in prescribing decisions: The Yemeni experience. Al-Areefi MA, Hassali MA, Mohamed Ibrahim MIb, Research in social & administrative pharmacy 2012 in press 23964257
27. Impact of pharmaceutical promotion on healthcare professional's practices and behaviour: views from general practitioners, medicine dispensers and medical representatives in Yemen. Al-Hamdi AY, Ahmad Hassali MA, Ibrahim MIM, Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 2012 12 4 240 246 10.1177/1745790412455942
28. Morse JM, Field PA, Nursing research: the application of qualitative approaches Cheltenham: Nelson Thornes 1996